SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $224,000 | -23.5% | 1,600 | 0.0% | 0.04% | -23.4% |
Q2 2019 | $293,000 | +15.4% | 1,600 | 0.0% | 0.05% | +14.6% |
Q1 2019 | $254,000 | +66.0% | 1,600 | 0.0% | 0.04% | +46.4% |
Q4 2018 | $153,000 | -32.3% | 1,600 | 0.0% | 0.03% | -20.0% |
Q3 2018 | $226,000 | -9.6% | 1,600 | 0.0% | 0.04% | -14.6% |
Q2 2018 | $250,000 | -13.8% | 1,600 | -11.1% | 0.04% | -12.8% |
Q1 2018 | $290,000 | -2.7% | 1,800 | -0.6% | 0.05% | +4.4% |
Q4 2017 | $298,000 | +127.5% | 1,810 | -13.8% | 0.04% | +104.5% |
Q3 2017 | $131,000 | -21.6% | 2,100 | 0.0% | 0.02% | -38.9% |
Q2 2017 | $167,000 | – | 2,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |